Bencomo HA

Language: Spanish
References: 9
Page: 1-4
PDF size: 212.46 Kb.

Text Extraction

No abstract.

REFERENCES

1. Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood. 2018;131(25):2773-81.

2. Compernolle V, Chou ST, Tanael S, Savage W, Howard J, Josephson CD, et al. Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline. Transfusion. 2018;58(6):1555-66.

3. Nance ST. Global definitions of rare donors. ISBT Sci Ser. 2013;8(1):23-7.

4. Ryder AB, Zimring JC, Hendrickson JE. Factors influencing RBC alloimmunization: lessons learned from murine models. Transfus Med Hemother. 2014;41:406-19.

5. Yazdanbakhsh K. Mechanisms of sickle cell alloimmunization. Transfus Clin Biol. 2015 August;22(3):178-81.

6. Yazdanbakhsh K, Shaz BH, Hillyer CD. Immune regulation of sickle cell alloimmunization. ISBT Sci Ser. 2017 Feb;12(1):248-53.

7. Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood. 2010;115:3989-96.

8. Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, et al. Relative immunogenicity of Fya and K antigens in a caucasian population, based on HLA class II restriction analysis. Transfusion 2006;46:1328-33.

9. Tatari-Calderone Z, Tamouza R, Le Bouder GP, Dewan R, Luban NL, Lasserre J, et al. The association of CD81 polymorphisms with alloimmunization in sickle cell disease. Clin Dev Immun. 2013; 2013: 937846.